Seamus Fernandez

Stock Analyst at Guggenheim

(4.96)
# 108
Out of 5,136 analysts
430
Total ratings
64.7%
Success rate
28.8%
Average return

Stocks Rated by Seamus Fernandez

Amylyx Pharmaceuticals
Nov 16, 2026
Reiterated: Buy
Price Target: $57
Current: $27.80
Upside: +105.04%
Sagimet Biosciences
Nov 15, 2026
Reiterated: Buy
Price Target: $26
Current: $10.13
Upside: +156.66%
Septerna
Nov 6, 2026
Rated: Buy
Price Target: $51 → $65
Current: $41.67
Upside: +55.99%
Rhythm Pharmaceuticals
Nov 4, 2026
Reiterated: Buy
Price Target: $143 → $147
Current: $107.48
Upside: +36.77%
Retension Pharmaceuticals
Nov 2, 2026
Initiated Coverage: Buy
Price Target: $55
Current: $11.46
Upside: +379.93%
Bristol-Myers Squibb Company
Oct 29, 2026
Reiterated: Buy
Price Target: $75
Current: $62.93
Upside: +19.18%
Aclaris Therapeutics
Oct 28, 2026
Reiterated: Buy
Price Target: $12
Current: $3.61
Upside: +232.87%
Kymera Therapeutics
Oct 28, 2026
Reiterated: Buy
Price Target: $170
Current: $125.85
Upside: +35.08%
Arcutis Biotherapeutics
Oct 19, 2026
Rated: Buy
Price Target: $38 → $44
Current: $27.15
Upside: +62.06%
Vaxcyte
Oct 18, 2026
Reiterated: Buy
Price Target: $125
Current: $61.61
Upside: +102.89%
Reiterated: Buy
Price Target: $150
Current: $53.12
Upside: +182.38%
Reiterated: Buy
Price Target: $14
Current: $3.32
Upside: +321.69%
Reiterated: Buy
Price Target: $1,273 → $1,284
Current: $1,431.67
Upside: -10.31%
Downgraded: Hold
Price Target: n/a
Current: $1.48
Upside: -
Reiterated: Buy
Price Target: $48 → $52
Current: $14.53
Upside: +257.88%
Reiterated: Hold
Price Target: n/a
Current: $8.31
Upside: -
Reiterated: Buy
Price Target: 16,500p → 16,200p
Current: 14,034p
Upside: +15.43%
Reiterated: Hold
Price Target: n/a
Current: $48.39
Upside: -
Reiterated: Buy
Price Target: $30
Current: $10.49
Upside: +185.99%
Reiterated: Buy
Price Target: $140
Current: $18.57
Upside: +653.90%
Reiterated: Buy
Price Target: €110.00 → €101.00
Current: €88.32
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $41.60
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $1.56
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $1,929.50
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $50.41
Upside: n/a
Reiterated: Buy
Price Target: $125 → $130
Current: $144.46
Upside: n/a
Reiterated: Buy
Price Target: $250 → $83
Current: $23.47
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $0.5377
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $149.70
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $135.76
Upside: n/a
Initiated Coverage: Hold
Price Target: n/a
Current: $160.20
Upside: n/a
Initiated Coverage: Buy
Price Target: $13
Current: $3.07
Upside: n/a
Reiterated: Buy
Price Target: n/a
Current: $4.22
Upside: n/a
Reiterated: Hold
Price Target: $37
Current: $28.86
Upside: n/a
Reiterated: Buy
Price Target: $108
Current: $8.45
Upside: n/a
Reiterated: Buy
Price Target: $52
Current: $3.20
Upside: n/a
Rated: Buy
Price Target: n/a
Current: $159.73
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $462.32
Upside: n/a
Rated: Buy
Price Target: n/a
Current: $952.40
Upside: n/a
Reiterated: Buy
Price Target: $125
Current: $282.55
Upside: n/a
Reiterated: Hold
Price Target: $56
Current: $30.15
Upside: n/a
Downgraded: Hold
Price Target: $4
Current: $28.59
Upside: n/a